Ilumya (Tildrakizumab-Asmn)

Ilumya is used to treat moderate to severe Plaque psoriasis. Ilumya belongs to a class of drugs known as monoclonal antibodies. The medication is provided as an injection that works within the body to balance an overreactive immune system. Ilumya can lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.

https://ilumya.com

Indication:

  • Plaque Psoriasis

Infusion Duration:

A circular graphic indicating a 10 to 15 second time, with a blue arrow forming a circle, a leaf, and a person icon, suggesting a quick or eco-friendly process.

Frequency:

  • Loading Dose: Injections at 0,4 weeks

  • Maintenance Dose: Every 12 weeks.

schedule a consultation